Keywords
telepharmacy
innovation
medical technology
electronic prescription
pharmaceutical care
remote consultation
digital health
artificial intelligence
pharmacovigilance
How to Cite
Abstract
The article presents an overview of modern approaches to the development of telemedicine and telepharmacy as innovative forms of providing medical and pharmaceutical services at a distance. The historical stages of the formation of telemedicine, its integration into pharmaceutical practice, the main principles of telepharmacy and the formats of its implementation are highlighted. The advantages of using telepharmacy are considered, including increasing the availability of pharmaceutical care, optimizing resources, improving the quality of pharmaceutical care, and reducing the burden on the healthcare system. The challenges and limitations of the development of telepharmacy were analyzed, including legal, ethical, and technological aspects, issues of licensing and personal data protection. Special attention is paid to the international experience of implementing telepharmaceutical services in the USA, EU countries, Canada and Australia. The current state and prospects for the development of telepharmacy in Ukraine in the context of the digitalization of healthcare are described. A special emphasis is placed on the role of artificial intelligence in supporting clinical decisions, automating pharmaceutical consultations, and introducing virtual pharmacists. Recommendations are proposed for the integration of telepharmacy into the national healthcare system and pharmaceutical practice.
References
1. WHO issues new guide to running effective telemedicine services. World Health Organization. 2022. URL: https://www.who.int/news/item/10-11-2022-who-issues-new-guide-to-running-effective-telemedicine-services
2. The impact of the COVID-19 pandemic on human mental health. Ministry of Health of Ukraine. 2025. URL: https://moz.gov.ua/uk/vpliv-pandemii-covid-19-na-psihichne-zdorovja-ljudini
3. Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P. 1–24. URL: https://doi.org/10.53933/sspmpm.v2i4.69
4. Haiduchok I., Shapovalov V. Forensic pharmacy and medicine: risks for pharmacotherapy of addiction and countering of illegal circulation of psychoactive substances in the COVID-19 рandemic. SSP Modern Pharmacy and Medicine. 2021. Vol.1. No.2. P. 1-28. DOI: https://doi.org/10.53933/sspmpm.v1i2.32
5. Craig J., Patterson V. Introduction to the Practice of Telemedicine. Journal of Telemedicine and Telecare. 2005. Vol. 11. No. 1. P. 3–9. DOI: https://doi.org/10.1177/1357633X0501100102
6. Dovzhuk V., Konovalova L., Dovzhuk N. et al. Prospects for the Use of Artificial Intelligence in Personalized Medicine, Pharmaceutical Design and Education. SSP Modern Pharmacy and Medicine. 2025. Vol.5. No.2. P.1-13. URL: https://doi.org/10.53933/sspmpm.v5i2.182
7. Titarenko I. Bioresonance therapy as an innovative method of bioquantum medicine. SSP Modern Pharmacy and Medicine. 2024. Vol. 4. No. 4. P. 1-20. DOI: https://doi.org/10.53933/sspmpm.v4i4.166
8. Shapovalova V. Innovative approaches to medical and pharmaceutical care, pharmacotherapy, and availability of pharmaceutical supplies for Tuberculosis patients in wartime. SSP Modern Pharmacy and Medicine. 2025. Vol. 5. No. 1. P. 1-17. URL: https://doi.org/10.53933/sspmpm.v5i1.170
9. Shapovalov V. Multidisciplinary Study of Medical Errors in the System of Legal Relations Between "Doctor-Patient-Pharmacist-Advocate" During the Circulation of Drugs. SSP Modern Pharmacy and Medicine, 2023. Vol. 3. No. 2. Р. 1-10. DOI: https://doi.org/10.53933/sspmpm.v3i2.88
10. WHO. Consolidated telemedicine implementation guide. World Health Organization. 2022. URL: https://www.who.int/publications/i/item/9789240059184
11. Institute of Medicine. Telemedicine: A Guide to Assessing Telecommunications in Health Care. National Academies Press. 1996. URL: https://www.ncbi.nlm.nih.gov/books/NBK45440/
12. Telepharmacy. Wikipedia. URL: https://uk.wikipedia.org/wiki/%D0%A2%D0%B5%D0%BB%D0%B5%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D1%86%D1%96%D1%8F
13. Pyndus V., Shapovalov V. Study of Pharmaceutical Provision Under the Program of Medical Guarantees in Ukraine. SSP Modern Pharmacy and Medicine. 2024. Vol. 4. No. 3. Р. 1-10. DOI: https://doi.org/10.53933/sspmpm.v4i3.155
14. Haider M.A., Razzaq J. Telemedicine in the United States: An Introduction for Students and Residents. JMIR Med Educ. 2020. PMCID: PMC7690251
15. DeRonne B., Wong K., Schultz E. et al. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder. American Journal of Health-System Pharmacy. 2021. Vol. 78. Iss. 4. P. 354–359. DOI: https://doi.org/10.1093/ajhp/zxaa405
16. Australian Digital Health Agency. Telehealth services. 2022. URL: https://www.digitalhealth.gov.au/initiatives-and-programs/telehealth-services
17. Poudel A., Nissen L. Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges. Integrated Pharmacy Research and Practice. 2016. Vol. 5. P. 75–82. DOI: https://doi.org/10.2147/IPRP.S99490
18. Sanyaolu A., et al. Applications of Artificial Intelligence in Telemedicine. Journal of Multidisciplinary Healthcare. 2022. Vol. 15. P. 223–231. DOI: https://doi.org/10.2147/JMDH.S332017
19. Ekeland A.G., Bowes A., Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. International Journal of Medical Informatics. 2010. Vol. 79. No 11. P. 736–771. DOI: https://doi.org/10.1016/j.ijmedinf.2010.08.006
20. Totten A.M., Womack D.M., Eden K.B., et al. Telehealth: Mapping the Evidence for Patient Outcomes from Systematic Reviews. Agency for Healthcare Research and Quality. 2016. Report No.: 16-EHC034-EF. URL: https://effectivehealthcare.ahrq.gov/products/telehealth/mapping-evidence-report
21. Weinstein R.S., Lopez A.M., Joseph B.A. et al. Telemedicine, Telehealth, and Mobile Health Applications that Work: Evidence for Their Effectiveness. Telemedicine and e-Health. 2014. Vol. 20. No 5. P. 399–404. DOI: https://doi.org/10.1089/tmj.2014.0043
22. Scott Kruse C., Karem P., Shifflett K. et al. Evaluating barriers to adopting telemedicine worldwide: A systematic review. Journal of Telemedicine and Telecare. 2018. Vol. 24. No 1. P. 4–12. DOI: https://doi.org/10.1177/1357633X16674087
23. Alexander E., Butler C.D., Darr A., Jenkins M.T. Navigating the Telepharmacy Frontier — A State-by-State Analysis. Journal of the American Pharmacists Association. 2021. Vol. 61. No 6. P. e14–e22. DOI: https://doi.org/10.1016/j.japh.2021.06.017
24. Baldoni S., Amenta F., Ricci G. Telepharmacy Services: Present Status and Future Perspectives: A Review. Medicina. 2019. Vol. 55. No 7. Article 327. DOI: https://doi.org/10.3390/medicina55070327
25. Win Azar M., Dizon J.M. Telemedicine and the Philippines: Potential, Prospects, and Challenges. Frontiers in Public Health. 2021. Vol. 9. Article 655048. DOI: https://doi.org/10.3389/fpubh.2021.655048
26. Bashshur R.L., Shannon G.W., Smith B.R. et al. The Empirical Foundations of Telemedicine Interventions for Chronic Disease Management. Telemedicine and e-Health. 2014. Vol. 20. No 9. P. 769–800. DOI: https://doi.org/10.1089/tmj.2014.9981
27. Almalki M., Giannicchi A. Telemedicine in the Era of COVID-19: The Rising Need for Telepharmacy Services. International Journal of Environmental Research and Public Health. 2021. Vol. 18. No 22. Article 12109. DOI: https://doi.org/10.3390/ijerph182212109
28. Dorsey E.R., Topol E.J. Telemedicine 2020 and the Next Decade. The Lancet. 2020. Vol. 395. No 10227. P. 859. DOI: https://doi.org/10.1016/S0140-6736(20)30424-4
29. Fatehi F., Armfield N.R., Gray L.C. Telemedicine for Clinical Management of Diabetes — A Process Analysis. Journal of Telemedicine and Telecare. 2014. Vol. 20. No 8. P. 432–438. DOI: https://doi.org/10.1177/1357633X14555643
30. Goundrey-Smith S. The Future of Pharmacy Practice: Implications of the Digital Revolution. Pharmacy. 2018. Vol. 6. No 1. Article 3. DOI: https://doi.org/10.3390/pharmacy6010003
31. Lam M.Y., Rose D. Telehealth in Pharmacy Practice: Improving Access to Care. Journal of the American Pharmacists Association. 2022. Vol. 62. No 2. P. 506–510. DOI: https://doi.org/10.1016/j.japh.2021.11.014
32. Koonin L.M., Hoots B., Tsang C.A. et al. Trends in the Use of Telehealth During the Emergence of the COVID-19 Pandemic — United States, January–March 2020. Morbidity and Mortality Weekly Report. 2020. Vol. 69. No 43. P. 1595–1599. DOI: https://doi.org/10.15585/mmwr.mm6943a3
33. Omboni S. Telemedicine During the COVID-19 in Italy: A Missed Opportunity? Telemedicine and e-Health. 2020. Vol. 26. No 8. P. 973–975. DOI: https://doi.org/10.1089/tmj.2020.0106
34. Ilkhanizadeh B., Heidari A., Aghamolaei T. Factors Affecting the Use of Telepharmacy Services: A Literature Review. Health Information Management Journal. 2022. Vol. 51. No 2. P. 73–85. DOI: https://doi.org/10.1177/18333583211035683
35. Marcin J.P., Shaikh U., Steinhorn R.H. Addressing Health Disparities in Rural Communities Using Telehealth. Pediatric Research. 2016. Vol. 79. No 1. P. 169–176. DOI: https://doi.org/10.1038/pr.2015.192
36. Monaghesh E., Hajizadeh A. The Role of Telehealth During COVID-19 Outbreak: A Systematic Review. Based on Current Evidence. BMC Public Health. 2020. Vol. 20. Article 1193. DOI: https://doi.org/10.1186/s12889-020-09301-4
37. McFarland M.S., Shannon D.M., Richards K.L. et al. Outcomes of Pharmacist-Provided Telepharmacy Services in Rural Hospitals: A Systematic Review and Meta-Analysis. Research in Social and Administrative Pharmacy. 2021. Vol. 17. No 9. P. 1572–1582. DOI: https://doi.org/10.1016/j.sapharm.2020.09.017
38. Bahlol M., Dewey R.S. Pandemic Preparedness: The Role of Telepharmacy in Pharmacist Services. Pharmacy Practice. 2020. Vol. 18. No 3. Article 2127. DOI: https://doi.org/10.18549/PharmPract.2020.3.2127
39. Dávila-Cervantes C.A., Agudelo-Botero M. Health Disparities in Latin America and the Caribbean: The Role of Telehealth. Globalization and Health. 2019. Vol. 15. No 1. Article 45. DOI: https://doi.org/10.1186/s12992-019-0493-8
40. Paudyal V., Cadogan C., Fialová D. et al. Provision of Clinical Pharmacy Services During the COVID-19 Pandemic: Experiences of Pharmacists from 16 European Countries. Research in Social and Administrative Pharmacy. 2021. Vol. 17. No 8. P. 1500–1508. DOI: https://doi.org/10.1016/j.sapharm.2020.11.017
41. Morillo-Verdugo R., Margusino-Framiñán L., Monte-Boquet E. et al. Spanish Society of Hospital Pharmacy Position Statement on Telepharmacy: Recommendations for its Implementation and Development. Farmacia Hospitalaria. 2020. Vol. 44. No 4. P. 135–140. DOI: https://doi.org/10.7399/fh.11465
42. Weitzel K.W., Goode J.V.R. Implementation of Pharmacy Services in Telehealth Models. Journal of the American Pharmacists Association. 2020. Vol. 60. No 2. P. e52–e63. DOI: https://doi.org/10.1016/j.japh.2019.11.011
43. Koziol J.E., Schnatz P.F. Pharmacists' Role in the Era of COVID-19. Journal of the American Pharmacists Association. 2020. Vol. 60. No 5. P. e103–e104. DOI: https://doi.org/10.1016/j.japh.2020.06.012
44. Albahri O.S., Zaidan A.A., Albahri A.S. et al. Telemedicine for Diabetes Management During COVID-19 Pandemic: A Systematic Review. Informatics in Medicine Unlocked. 2021. Vol. 23. Article 100535. DOI: https://doi.org/10.1016/j.imu.2021.100535
45. Jiménez-Rodríguez D., García-González J., Robles-Rodríguez J. et al. Increase in the Use of Telehealth in Primary Care During the COVID-19 Pandemic: A Retrospective Cohort Study. Journal of Telemedicine and Telecare. 2022. Vol. 28. No 8. P. 544–551. DOI: https://doi.org/10.1177/1357633X211013196
46. Mehrotra A., Ray K., Brockmeyer D.M., et al. Rapidly Converting to "Virtual Practices": Outpatient Care in the Era of COVID-19. NEJM Catalyst Innovations in Care Delivery. 2020. Vol. 1. No 2. DOI: https://doi.org/10.1056/CAT.20.0091
47. Hollander J.E., Carr B.G. Virtually Perfect? Telemedicine for Covid-19. New England Journal of Medicine. 2020. Vol. 382. No 18. P. 1679–1681. DOI: https://doi.org/10.1056/NEJMp2003539
48. Smith A.C., Thomas E., Snoswell C.L., et al. Telehealth for Global Emergencies: Implications for Coronavirus Disease 2019 (COVID-19). Journal of Telemedicine and Telecare. 2020. Vol. 26. No 5. P. 309–313. DOI: https://doi.org/10.1177/1357633X20916567
49. Tuckson R.V., Edmunds M., Hodgkins M.L. Telehealth. New England Journal of Medicine. 2017. Vol. 377. No 16. P. 1585–1592. DOI: https://doi.org/10.1056/NEJMra1616186
50. Villalba-Mora E., Casas I., Lupiañez-Villanueva F., Maghiros I. Adoption of Health Information Technologies by Physicians for Clinical Practice: The Andalusian Case. International Journal of Medical Informatics. 2015. Vol. 84. No 7. P. 477–485. DOI: https://doi.org/10.1016/j.ijmedinf.2015.03.002
51. Fatehi F., Menon A., Bird D. Diabetes Care in the Digital Era: A Synopsis of Current Practices and Future Prospects. Journal of Diabetes Science and Technology. 2017. Vol. 11. No 5. P. 799–805. DOI: https://doi.org/10.1177/1932296817716396
52. Portnoy J., Waller M., Elliott T. Telemedicine in the Era of COVID-19. Journal of Allergy and Clinical Immunology: In Practice. 2020. Vol. 8. No 5. P. 1489–1491. DOI: https://doi.org/10.1016/j.jaip.2020.03.008
53. Zhai Y., Wang Y., Zhang M. et al. From Isolation to Coordination: How Can Telemedicine Help Combat the COVID-19 Outbreak? Public Health. 2020. Vol. 183. P. 36–39. DOI: https://doi.org/10.1016/j.puhe.2020.03.010
54. Monaghesh E., Hajizadeh A. The Role of Telehealth During COVID-19 Outbreak: A Systematic Review Based on Current Evidence. BMC Public Health. 2020. Vol. 20. Article 1193. DOI: https://doi.org/10.1186/s12889-020-09301-4
55. Gagnon M.P., Duplantie J., Fortin J.P., Landry R. Implementing Telehealth to Support Medical Practice in Rural/Remote Regions: What Are the Conditions for Success? Implementation Science. 2006. Vol. 1. No 1. Article 18. DOI: https://doi.org/10.1186/1748-5908-1-18
56. Kruse C.S., Krowski N., Rodriguez B. et al. Telehealth and Patient Satisfaction: A Systematic Review and Narrative Analysis. BMJ Open. 2017. Vol. 7. No 8. Article e016242. DOI: https://doi.org/10.1136/bmjopen-2017-016242
57. Bashshur R.L., Shannon G.W., Krupinski E.A., Grigsby J. Sustaining and Realizing the Promise of Telemedicine. Telemedicine and e-Health. 2013. Vol. 19. No 5. P. 339–345. DOI: https://doi.org/10.1089/tmj.2012.0282
58. Anglada-Martínez H., Rius L., Martin-Conde M. et al. Does mHealth Increase Adherence to Medication? A Systematic Review and Meta-Analysis. Journal of Medical Internet Research. 2015. Vol. 17. No 9. Article e310. DOI: https://doi.org/10.2196/jmir.4513
59. Baines R.J., Langelaan M., de Bruijne M.C. et al. Changes in Patient Safety Culture Following the Introduction of Telemonitoring in Homecare: A Pre-Post Study. BMC Health Services Research. 2018. Vol. 18. Article 604. DOI: https://doi.org/10.1186/s12913-018-3392-0
60. Zhao J., Freeman B., Li M. Can Mobile Phone Apps Influence People's Health Behavior Change? An Evidence Review. Journal of Medical Internet Research. 2016. Vol. 18. No 11. Article e287. DOI: https://doi.org/10.2196/jmir.5692
61. Chaet D., Clearfield R., Sabin J.E., Skimming K. Ethical Practice in Telehealth and Telemedicine. Journal of General Internal Medicine. 2017. Vol. 32. No 10. P. 1136–1140. DOI: https://doi.org/10.1007/s11606-017-4082-2
62. Hsu M.H., Chiu C.M. Internet Self-Efficacy and Electronic Service Acceptance. Decision Support Systems. 2004. Vol. 38. No 3. P. 369–381. DOI: https://doi.org/10.1016/j.dss.2003.08.001
63. Batsis J.A., DiMilia P.R., Seo L.M. et al. Effectiveness of Ambulatory Telemedicine Care in Older Adults: A Systematic Review. Journal of the American Geriatrics Society. 2019. Vol. 67. No 8. P. 1737–1749. DOI: https://doi.org/10.1111/jgs.15959
64. Kairy D., Lehoux P., Vincent C., Visintin M. A Systematic Review of Clinical Outcomes, Clinical Process, Healthcare Utilization and Costs Associated with Telerehabilitation. Disability and Rehabilitation. 2009. Vol. 31. No 6. P. 427–447. DOI: https://doi.org/10.1080/09638280802062553
65. Dorsey E.R., Topol E.J. State of Telehealth. New England Journal of Medicine. 2016. Vol. 375. No 2. P. 154–161. DOI: https://doi.org/10.1056/NEJMra1601705
66. Omboni S., McManus R.J., Bosworth H.B., et al. Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension. Hypertension. 2020. Vol. 76. No 5. P. 1368–1383. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.15873
67. Calton B., Abedini N., Fratkin M. Telemedicine in the Time of Coronavirus. Journal of Pain and Symptom Management. 2020. Vol. 60. No 1. P. e12–e14. DOI: https://doi.org/10.1016/j.jpainsymman.2020.03.019
68. Wootton R. Twenty Years of Telemedicine in Chronic Disease Management — An Evidence Synthesis. Journal of Telemedicine and Telecare. 2012. Vol. 18. No 4. P. 211–220. DOI: https://doi.org/10.1258/jtt.2012.120219
69. Contreras C.M., Metzger G.A., Beane J.D. et al. Telemedicine: Patient-Provider Clinical Engagement During the COVID-19 Pandemic and Beyond. Journal of Gastrointestinal Surgery. 2020. Vol. 24. No 7. P. 1692–1697. DOI: https://doi.org/10.1007/s11605-020-04623-5
70. Rutledge C.M., Mason A.M., Chike-Harris K. et al. Telehealth Education: An Interprofessional Online Immersion Experience in Response to COVID-19. Journal of Interprofessional Care. 2020. Vol. 34. No 5. P. 700–703. DOI: https://doi.org/10.1080/13561820.2020.1813691
71. Almathami H.K.Y., Win K.T., Vlahu-Gjorgievska E. Barriers and Facilitators that Influence Telemedicine-Based, Real-Time, Online Consultation at Patients' Homes: Systematic Literature Review. Journal of Medical Internet Research. 2020. Vol. 22. No 2. Article e16407. DOI: https://doi.org/10.2196/16407
72. Dullet N.W., Geraghty E.M., Kaufman T. et al. Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants. Value in Health. 2017. Vol. 20. No 4. P. 542–546. DOI: https://doi.org/10.1016/j.jval.2017.01.014
73. Dixon B.E., Hook J.M., McGowan J.J. Using Telehealth to Improve Quality and Safety: Findings from the AHRQ Portfolio. Health Affairs. 2008. Vol. 27. No 5. P. 1267–1272. DOI: https://doi.org/10.1377/hlthaff.27.5.1267
74. Smith S., Thomas E., Snoswell C.L. et al. Telehealth for Global Emergencies: Implications for Coronavirus Disease 2019 (COVID-19). Journal of Telemedicine and Telecare. 2020. Vol. 26. No 5. P. 309–313. DOI: https://doi.org/10.1177/1357633X20916567
75. Campagna S., Bouchard M. Telepharmacy: A New Opportunity for Community Pharmacists. Canadian Pharmacists Journal. 2019. Vol. 152. No 3. P. 139–142. DOI: https://doi.org/10.1177/1715163519837690
76. Upadhyay S., Pal R., Mallick D. Telemedicine: Need of the Hour During the COVID-19 Pandemic. Diabetes and Metabolic Syndrome. 2020. Vol. 14. No 5. P. 1445–1447. DOI: https://doi.org/10.1016/j.dsx.2020.07.020
77. DeSimone E., Hayen R., Needham K. et al. Implementation of a Telepharmacy Service for Remote Dispensing and Medication Counseling. Journal of Pharmacy Practice and Research. 2021. Vol. 51. No 3. P. 228–234. DOI: https://doi.org/10.1002/jppr.1737
78. Alhusseini N., Galea E.R., Thomas A. et al. Healthcare Delivery for Low-Income Patients: The Role of Telepharmacy. American Journal of Health-System Pharmacy. 2021. Vol. 78. No 8. P. 729–734. DOI: https://doi.org/10.1093/ajhp/zxaa430
79. Reeves J.J., Hollandsworth H.M., Torriani F.J. et al. Rapid Response to COVID-19: Health Informatics Support for Outbreak Management in an Academic Health System. Journal of the American Medical Informatics Association. 2020. Vol. 27. No 6. P. 853–859. DOI: https://doi.org/10.1093/jamia/ocaa037
80. Greenhalgh T., Wherton J., Shaw S. et al. Video Consultations for COVID-19. BMJ. 2020. Vol. 368. Article m998. DOI: https://doi.org/10.1136/bmj.m998
81. Lin M.H., Yuan W.L., Huang T.C. et al. Clinical Effectiveness of Telemedicine for Chronic Heart Failure: A Systematic Review and Meta-Analysis. Journal of Investigative Medicine. 2017. Vol. 65. No 5. P. 899–911. DOI: https://doi.org/10.1136/jim-2016-000290
82. Espinoza J., Crown K., Kulkarni O. A Guide to Chatbots for COVID-19 Screening at Pediatric Health Care Facilities. Journal of Pediatric Health Care. 2020. Vol. 34. No. 3. P. 274–277. DOI: https://doi.org/10.1016/j.pedhc.2020.03.002
83. Bashshur R., Doarn C.R., Frenk J.M. et al. Telemedicine and the COVID-19 Pandemic: Lessons for the Future. Telemedicine and e-Health. 2020. Vol. 26. No. 5. P. 571–573. DOI: https://doi.org/10.1089/tmj.2020.29040.rb
84. Serper M., Volk M.L. Current and Future Applications of Telemedicine to Optimize the Delivery of Care in Chronic Liver Disease. Clinical Gastroenterology and Hepatology. 2018. Vol. 16. No. 2. P. 157–161. DOI: https://doi.org/10.1016/j.cgh.2017.10.004
85. Martínez-Alcalá C.I., Rosales-Lagarde A., Alonso-Lavernia M.D. et al. Telemedicine and Telehealth: Review of the Literature and Evolution of Telemedicine. Health Informatics Journal. 2021. Vol. 27. No. 1. P. 146–169. DOI: https://doi.org/10.1177/1460458220953124
86. Tuckson R.V., Edmunds M., Hodgkins M.L. Telehealth. New England Journal of Medicine. 2017. Vol. 377. No. 16. P. 1585–1592. DOI: https://doi.org/10.1056/NEJMra1616186
87. Thomas E.E., Haydon H.M., Mehrotra A. et al. Building on the Momentum: Sustaining Telehealth Beyond COVID-19. Journal of Telemedicine and Telecare. 2022. Vol. 28. No. 4. P. 301–308. DOI: https://doi.org/10.1177/1357633X211062907
88. Elson E.C., Oermann C., Duehlmeyer S. et al. Use of Telemedicine to Provide Clinical Pharmacy Services During the SARS-CoV-2 Pandemic. American Journal of Health-System Pharmacy. 2020. Vol. 77. No. 13. P. 1005–1008. DOI: https://doi.org/10.1093/ajhp/zxaa103
89. Li P., Luo Y., Yu X. et al. Use of Telemedicine for Chronic Disease Management in the COVID-19 Era: A Systematic Review and Meta-Analysis. Journal of Medical Internet Research. 2021. Vol. 23. No. 8. Article e27474. DOI: https://doi.org/10.2196/27474
90. Totten A.M., Hansen R.N., Wagner J. et al. Telehealth for Acute and Chronic Care Consultations. Agency for Healthcare Research and Quality. 2019. Report No. 19-EHC012-EF. URL: https://effectivehealthcare.ahrq.gov/products/telehealth-acute-chronic/research
91. Leite H., Lindsay C., Kumar M. COVID-19 Outbreak: Implications on Healthcare Operations. TQM Journal. 2020. Vol. 33. No. 1. P. 231–240. DOI: https://doi.org/10.1108/TQM-05-2020-0117
92. Zhai Y., Wang Y., Zhang M. et al. From Isolation to Coordination: How Can Telemedicine Help Combat the COVID-19 Outbreak? Public Health. 2020. Vol. 183. P. 36–39. DOI: https://doi.org/10.1016/j.puhe.2020.03.010
93. Nguyen M., Waller M., Pandya A., Portnoy J. A Review of Patient and Provider Satisfaction with Telemedicine. Current Allergy and Asthma Reports. 2020. Vol. 20. Article 72. DOI: https://doi.org/10.1007/s11882-020-00969-7
94. Kane C.K., Gillis K. The Use of Telemedicine by Physicians: Still the Exception Rather Than the Rule. Health Affairs. 2018. Vol. 37. No. 12. P. 1923–1930. DOI: https://doi.org/10.1377/hlthaff.2018.05077
95. Wosik J., Fudim M., Cameron B., et al. Telehealth Transformation: COVID-19 and the Rise of Virtual Care. Journal of the American Medical Informatics Association. 2020. Vol. 27. No. 6. P. 957–962. DOI: https://doi.org/10.1093/jamia/ocaa067
96. Reed M.E., Huang J., Graetz I. et al. Patient Characteristics Associated with Choosing a Telemedicine Visit vs Office Visit with the Same Primary Care Providers. JAMA Network Open. 2020. Vol. 3. No. 6. Article e205873. DOI: https://doi.org/10.1001/jamanetworkopen.2020.5873
97. Loeb A.E., Rao S.S., Ficke J.R. et al. Departmental Experience and Lessons Learned with Accelerated Introduction of Telemedicine During the COVID-19 Crisis. Journal of the American Academy of Orthopaedic Surgeons. 2020. Vol. 28. No. 11. P. e469–e476. DOI: https://doi.org/10.5435/JAAOS-D-20-00380
98. Chou E., Hsieh Y.L., Wolfshohl J. et al. Onsite Telemedicine Strategy for Coronavirus (COVID-19) Screening to Limit Exposure in ED. Emergency Medicine Journal. 2020. Vol. 37. No. 6. P. 335–337. DOI: https://doi.org/10.1136/emermed-2020-209710
99. Caffery L.J., Farjian M., Smith A.C. Telehealth Interventions for Reducing Waiting Lists and Waiting Times for Specialist Outpatient Services: A Scoping Review. Journal of Telemedicine and Telecare. 2016. Vol. 22. No. 8. P. 504–512. DOI: https://doi.org/10.1177/1357633X16670495
100. Sabesan S., Kelly J. Are Teleoncology Models Merely About Avoiding Travel Time? Practical Telemedicine Concepts for the Future. Current Oncology Reports. 2014. Vol. 16. No. 11. Article 382. DOI: https://doi.org/10.1007/s11912-014-0382-1
101. Australian Digital Health Agency. Telehealth services. 2022. URL: https://www.digitalhealth.gov.au/initiatives-and-programs/telehealth-services
102. Shapovalov V. Medical and pharmaceutical law: deepening the cooperation between the LMI, KhMAPE* and Estonian Scientific Publishing House SSP OÜ, as part of the system of Ukraine’s integration into the European Community. SSP Modern Law and Practice. 2022. Vol.2. No.2. P.1-12. URL: https://doi.org/10.53933/sspmlp.v2i2.51
103. Shapovalov V., Samorodov A. Ebaseaduslik Narkootikumide Ringlus Koroonaviiruse Pandeemia Ajal: Kohtuekspertiisi Apteek, Farmaatsiaäri Organisatsioon Ja Kriminaalõigus Salakaubaveo Interdistsiplinaarse Uurimise Alusena. SSP Modern Law and Practice. 2023. Vol.3. No.1. P.1-19. URL: https://doi.org/10.53933/sspmlp.v3i1.80
104. Poudel A., Nissen L. Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges. Integrated Pharmacy Research and Practice. 2016. No. 5. P. 75–82. DOI: https://doi.org/10.2147/IPRP.S99490
105. Ortega G., Rodriguez J.A., Maurer L.R., et al. Telemedicine, COVID-19, and Disparities: Policy Implications. Health Policy and Technology. 2020. Vol. 9. No. 3. P. 368–371. DOI: https://doi.org/10.1016/j.hlpt.2020.08.003
106. The impact of the COVID-19 pandemic on human mental health. Ministry of Health of Ukraine.2025. URL: https://moz.gov.ua/uk/vpliv-pandemii-covid-19-na-psihichne-zdorovja-ljudini
107. Chuiev Yu., Konovalova L. Multidisciplinary organizational and legal, forensic and pharmaceutical, medical and immunological researches in the organization and management of pharmaceutical competencies during the circulation of drugs in the relief of alcoholic addiction. SSP Modern Pharmacy and Medicine. 2022. Vol.2. No.2. P.1-11. URL: https://doi.org/10.53933/sspmpm.v2i2.48
108. Titarenko I. Application of Innovative Digital Medical Technologies of Bioquantum Medicine and Therapy in Elimination of Allergy Symptoms. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.3. P.1-10. URL: https://doi.org/10.53933/sspmpm.v4i3.156
109. Sanyaolu A. Applications of Artificial Intelligence in Telemedicine. Journal of Multidisciplinary Healthcare. 2022. Vol. 15. P. 223–231. DOI: https://doi.org/10.2147/JMDH.S332017
110. Hursman A., Vang Ch., Thooft T., Stone K. The Role of Telepharmacy in the Delivery of Clinical Pharmacy Services Following the COVID-19 Pandemic: A Descriptive Report. Journal Pharm.Technol. 2024. Vol. 40. Iss.2. P. 66-71. URL: https://pubmed.ncbi.nlm.nih.gov/38525089/
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Viktoriia Shapovalova (Author)